May 28, 20211 min
$BNTX +3% Pfizer and BioNTech Receive First Authorization in European Union for COVID-19 Vaccine in Adolescents. source
$HGEN -11% Humanigen Submits Application to FDA for Emergency Use Authorization for Lenzilumab in COVID-19. source
$OMER +3% OMEROS ANNOUNCES PRELIMINARY RESULTS FROM ADDITIONAL CRITICALLY ILL COVID-19 PATIENTS TREATED WITH NARSOPLIMAB. source
$BBIO +2% bridgebio pharma’s affiliate qed therapeutics and partner helsinn group announce fda approval of truseltiq™ (infigratinib) for patients with cholangiocarcinoma. source
$LMNL -1% Liminal BioSciences Provides an Update on Currently Planned Clinical Activities for Fezagepras. source
$CALT +1% Calliditas Announces Submission of Marketing Authorisation Application for Nefecon to the European Medicines Agency. source
$ETON -20% Eton Pharmaceuticals Receives Complete Response Letter from U.S. FDA for Dehydrated Alcohol Injection. source
$AZN -1% Tagrisso approved in the EU for the adjuvant treatment of patients with early-stage EGFR-mutated lung cancer. source
$PRVB -28% FDA Advisory Committee Votes in Favor of the Benefits of Teplizumab Outweighing the Risks in Support of Approval to Delay Clinical Type 1 Diabetes (T1D). source
$ADMS +10% Adamis Pharmaceuticals Announces Receipt of Deficiency Letter from NASDAQ. source
Posted by DV